CNBC reports:
– Albert Bourla, chairman and CEO of Pfizer, hailed the trial results as a “great day for science and humanity.”
– Pfizer and BioNTech said the case split between vaccinated individuals and those who received a placebo indicated a vaccine efficacy rate of above 90% at seven days after the second dose.
– It means that protection from Covid-19 is achieved 28 days after the initial vaccination, which consists of a …
The post CNBC: Pfizer, BioNTech say late-stage trial data shows Covid vaccine is more than 90% effective in preventing infection appeared first on The Loadstar.
Source: The Loadstar
Be the first to comment on "CNBC: Pfizer, BioNTech say late-stage trial data shows Covid vaccine is more than 90% effective in preventing infection"